Dexmedetomidine decreases cerebral hyperperfusion incidence following carotid stenting: A double-blind, randomized controlled trial
This work was funded by National Natural Science Foundation of China (no. 82271288) and the Henan Provincial Science and Technology Research Project (nos. 242300421192 and JQRC2023004).
Authors
- Lingzhi Wu
- Jinpeng Zhou (ORCID: https://orcid.org/0000-0002-7262-1119)
- Enqiang Chang (ORCID: https://orcid.org/0000-0001-7415-8845)
- Xinyi Li (ORCID: https://orcid.org/0000-0002-3558-3977)
- Li Li (ORCID: https://orcid.org/0009-0006-7961-7354)
- Jiaqiang Zhang (ORCID: https://orcid.org/0000-0002-1367-9644)
- Tianxiao Li (ORCID: https://orcid.org/0000-0003-3585-5001)
- Daqing Ma (ORCID: https://orcid.org/0000-0003-1235-0537)
- Guanyu Chen (ORCID: https://orcid.org/0000-0002-2773-8748)
- Hui Zhi (ORCID: https://orcid.org/0000-0003-3229-0172)
- Jiaqi Bi (ORCID: https://orcid.org/0000-0002-3106-9225)
- Min Sun (ORCID: https://orcid.org/0009-0007-6886-3565)
Institutions
- Western University (CA)
- Zhengzhou University (CN)
- Henan Provincial People's Hospital (CN)
- Chelsea and Westminster Hospital (GB)
- Henan Cancer Hospital (CN)
- Imperial College London (GB)
Publication Details
- Journal
- Med
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1016/j.medj.2024.09.012
- Citations
- 7
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.93
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
- Henan Provincial Science and Technology Research Project